Table 3 Description of the treatment used by the psychiatric patients
From: COVID-19 outbreak in a psychiatric hospital: what makes it worse?
Frequency (%) | |
|---|---|
Psychiatric treatment | |
Atypical ATP | |
Yes | 133 (32.4%) |
No | 277 (67.6%) |
Typical ATP | |
Yes | 301 (73.4%) |
No | 109 (26.6%) |
Mood stabilizer | |
Yes | 37 (9.0%) |
No | 373 (91.0%) |
Benzodiazepines | |
Yes | 149 (36.3%) |
No | 261 (63.7%) |
Antiepileptic | |
Yes | 187 (45.6%) |
No | 223 (54.4%) |
Anticholinergic | |
Yes | 54 (64.3%) |
No | 30 (35.7%) |
Antidepressant SSRI | |
Yes | 21 (5.1%) |
No | 389 (94.9%) |
Antidepressant TCA | |
Yes | 18 (4.4%) |
No | 392 (95.6%) |
Number of neuroleptics used | |
0 | 67 (16.3%) |
1 | 140 (34.1%) |
> 1 | 203 (49.5%) |
Medical treatment | |
Anti-hypertensive | |
Yes | 69 (16.8%) |
No | 341 (83.2%) |
Anti-diabetic | |
Yes | 46 (11.2%) |
No | 364 (88.8%) |
Anti-coagulant | |
Yes | 23 (5.6%) |
No | 387 (94.4%) |
Statin | |
Yes | 31 (7.6%) |
No | 379 (92.4%) |